Printer Friendly

SOMANETICS CORPORATION ANNOUNCES FIRST QUARTER RESULTS

 TROY, Mich., April 16 /PRNewswire/ -- Somanetics Corporation (NASDAQ-NMS: SMTS) reported a net loss of $1,639,038, or $0.16 per Common Share, for the quarter ended Feb. 28, 1993, compared to a net loss of $875,401, or $0.14 per Common Share, for the same period of 1992.
 According to Raymond W. Gunn, chief financial officer, the Company is preparing for the initial commercial shipments of its proprietary INVOS(R) 3100 Cerebral Oximeter and related disposable SomaSensor(R), which are expected to commence by the end of the second fiscal quarter ended May 31, 1993. The first quarter loss included significant expenditures related to the implementation of a worldwide product pre-launch marketing and demonstration program for the Cerebral Oximeter, targeted to physician customers.
 Other expenses related to expanding the international sales and distribution network, resulting in the addition of nine specialty dealers to the sales network during the period. In addition, the Somanetics employee base has grown by approximately 60 percent over the same period in 1992, now employing 44 at its Troy, Mich., office.
 During the quarter, the Company received proceeds of $114,664 from the exercise of 28,666 Class B Warrants, and issued 28,666 Common Shares as a result of the exercises.
 Somanetics Corporation develops, markets and manufactures computer- based medical diagnostic and monitoring equipment using In Vivo Optical Spectroscopy (INVOS) technology. The company has developed the INVOS 3100 Cerebral Oximeter which noninvasively, directly and continuously measures oxygen saturation of the blood in portions of an adult's brain. The device is intended for use in a hospital's operating room, intensive care unit, recovery room and emergency room. Somanetics' Common Shares and Class B Warrants are traded on the NASDAQ National Market System under the symbols SMTS and SMTSZ, respectively.
 SOMANETICS CORPORATION
 (A development stage company)
 SELECTED INCOME STATEMENT DATA
 FOR THE FISCAL QUARTERS ENDED FEB. 28, 1993 AND FEB. 29, 1992
 (In thousands, except share and per-share data)
 Cumulative
 For The Period
 Jan. 15, 1982
 Three Months Ended (Date of Inception)
 Feb. 28, Feb. 29, To Feb. 28,
 1993 1992 1993
 (unaudited) (unaudited)
 Total revenues $0 $0 $1,251
 Gross margin 0 0 895
 Net loss (1,639) (875) ($15,241)
 Net loss per common share ($0.16) ($0.14) ($4.80)
 Weighted average number
 of common
 shares outstanding 10,343,706 6,242,183 3,174,062
 SOMANETICS CORPORATION
 (A development stage company)
 SELECTED BALANCE SHEET DATA
 FEB. 28, 1993 AND NOV. 30, 1992
 (In thousands)
 Feb. 28, Nov. 30,
 1993 1992
 (unaudited) (audited)
 Working capital $7,096 $8,776
 Total assets 8,797 10,310
 Total liabilities 847 835
 Long-term debt and redeemable convertible
 preferred shares 75 80
 Shareholders' equity $7,950 $9,475
 -0- 4/16/93
 /CONTACT: Mary Ann Robb, director of Corporate Communications, Somanetics, 313-689-3996/
 (SMTS)


CO: Somanetics Corporation ST: Michigan IN: MTC SU: ERN

SM-ML -- DE015 -- 0963 04/16/93 14:58 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 16, 1993
Words:485
Previous Article:AT&T TO INCORPORATE NEW 'CLIPPER' CHIP INTO SECURE COMMUNICATIONS PRODUCT LINE
Next Article:CERADYNE ANNOUNCES OPERATING RESULTS FOR THE FIRST QUARTER OF 1993
Topics:


Related Articles
SOMANETICS CORPORATION ANNOUNCES FIRST-QUARTER RESULTS
SOMANETICS CORPORATION ANNOUNCES FISCAL SECOND-QUARTER RESULTS
SOMANETICS' SECOND QUARTER RESULTS INCLUDE FIRST REVENUES FROM COMMERCIAL SALES OF CEREBRAL OXIMETER
SOMANETICS ANNOUNCES EXTENSION OF REDEMPTION DATE FOR CLASS B WARRANTS TO DEC. 29, 1993
SOMANETICS ANNOUNCES THIRD-QUARTER RESULTS
Somanetics Announces First Quarter Results
Somanetics Announces First Quarter Results
Somanetics Corporation to Release First Quarter Financial Results and Host Conference Call March 15.
Somanetics Corporation to Release First Quarter Financial Results and Host Conference Call March 15.
Somanetics Corporation to Release First Quarter 2007 Financial Results and Host Conference Call March 14.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters